Dermapharm Holding SE (ETR:DMP)
34.95
-0.20 (-0.57%)
Jul 9, 2025, 10:19 AM CET
Dermapharm Holding SE Revenue
Dermapharm Holding SE had revenue of 305.26M EUR in the quarter ending March 31, 2025, with 1.27% growth. This brings the company's revenue in the last twelve months to 1.20B, up 6.20% year-over-year. In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B with 3.89% growth.
Revenue (ttm)
1.20B
Revenue Growth
+6.20%
P/S Ratio
1.58
Revenue / Employee
332.22K
Employees
3,610
Market Cap
1.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.20B | 44.72M | 3.89% |
Dec 31, 2023 | 1.15B | 110.19M | 10.59% |
Dec 31, 2022 | 1.04B | 80.46M | 8.38% |
Dec 31, 2021 | 960.09M | 151.78M | 18.78% |
Dec 31, 2020 | 808.31M | 93.94M | 13.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
Dermapharm Holding SE News
- 4 days ago - EQS-DD: Dermapharm Holding SE: Wilhelm Beier, buy - Wallstreet:Online
- 14 days ago - EQS-DD: Dermapharm Holding SE: Dr. Andreas Eberhorn, buy - Wallstreet:Online
- 4 weeks ago - EQS-DD: Dermapharm Holding SE: Anja Schorn, buy - Wallstreet:Online
- 5 weeks ago - EQS-DD: Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy - Wallstreet:Online
- 7 weeks ago - Dermapharm Hits Q1 Targets, Reaffirms 2025 Outlook - Wallstreet:Online
- 3 months ago - EQS-PVR: Dermapharm Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 3 months ago - EQS-DD: Dermapharm Holding SE: Susanne Gertrud Pia Lanz, buy - Wallstreet:Online
- 3 months ago - Dermapharm's 2024: Revenue Soars, Surpassing EBITDA Expectations - Wallstreet:Online